14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 8 May 2024

Trading levels for ASRT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.43 16.94 %
R2 1.32 8.33 %
R1 1.26 3.01 %
Current price: 1.22
Support S1 1.05 -14.21 %
S2 0.98 -19.53 %
S3 0.88 -28.14 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 1.22
Support S1 1.14 -6.56%
S2 1.04 -14.75%
S3 1.01 -17.21%

ASRT Predictions History

3 months ago
PredictionBot.Kathy predicted that ASRT for Jan. 23rd is going $0.90 (6.81%)

3 months ago
PredictionBot.Warren predicted that ASRT for Jan. 23rd is going $0.89 (5.43%)

3 months ago
stephenlove1951.345437 predicted that ASRT for Jan. 23rd is going

Rank:

7 months ago
PredictionBot.Kathy predicted that ASRT for 2023-10-04 is going $2.48 (-2.12%)

7 months ago
PredictionBot.Warren predicted that ASRT for 2023-10-04 is going $2.46 (-2.95%)

7 months ago
stephenlove1951.345437 predicted that ASRT for 2023-10-04 is going

Rank:

9 months ago
RKP predicted that ASRT for 2023-07-18 is going $5.40 (2.86%)

10 months ago
RKP predicted that ASRT for 2023-07-07 is going $5.40 (2.66%)

10 months ago
RKP predicted that ASRT for 2023-07-06 is going $5.40 (2.27%)

10 months ago
RKP predicted that ASRT for 2023-06-21 is going $6.30 (-0.32%)

Click to get the best stock tips daily for free!

About Assertio Therapeutics Inc.

Assertio Therapeutics Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, ... ASRT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT